CRP and Insulin resistance: The change in the oleoylethanolamide/palmitoylethanolamide (OEA/PEA) endocannabinoid ratio following the MedDiet also diminished the homeostatic model assessment of insulin resistance index and decreased serum high-sensitive CRP, a measure of systemic inflammation.